What are the strategies adopted by the top market players for Solvent Evaporation Market?

Comments · 483 Views

What are the strategies adopted by the top market players for Solvent Evaporation Market?

Global solvent evaporation market size is projected to reach USD 694 million by 2024 from USD 487 million in 2019, at a CAGR of 7.3%.  The North American market is estimated to account for the largest share. The large share of this segment can be attributed to the increase in life sciences R&D, rising focus on improving the safety and quality of healthcare, growing efforts to increase the output of the healthcare industry, growth in the biosimilars and generics market, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics.

 

Request Sample of Report @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=68290365

 

Growth in this market is driven majorly by the growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals.

 

Key Market Players

The prominent players in the global solvent evaporation market include Yamato Scientific Co., Ltd. (Japan), BÜCHI Labortechnik AG (Switzerland), Biotage AB (Sweden), Heidolph Instruments GmbH & CO. KG (Germany), Labconco Corporation (US), Porvair plc (UK), IKA Works GmbH & Co. KG (Germany), Steroglass Srl (Italy), Organomation Associates, Inc. (US), KNF Neuberger, Inc. (US), BioChromato, Inc. (Japan), Radleys (UK), LabTech S.r.l. (Italy), Abel Industries Canada Ltd. (Canada), DOÐA Limited (Turkey), ANPEL Laboratory Technologies Inc. (China), Asahi Glassplant Inc. (Japan), EYELA (Japan), Pope Scientific, Inc. (US), and SP Industries, Inc. (UK).

BÜCHI Labortechnik AG (Switzerland) is a prominent player in the global solvent evaporators market. The company has a strong geographic footprint, serving over 40,000 customers operating in the pharmaceutical and biopharmaceutical space. BÜCHI also has an extensive distribution channel across the globe. The company offers a variety of reliable solutions during the production of a new drug, from lead generation to final registration.

Heidolph Instruments GmbH & CO. KG (Germany) is a leading provider of advanced rotary evaporators for drug manufacturing, biologics research and production, and laboratory testing. Heidolph’s key advantage over its competitors is that it leverages its industry scale in high-growth and emerging markets such as China and India.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68290365

Biotage AB (Sweden) offers a wide range of nitrogen blowdown evaporators like TurboVap Evaporators and 96 Well Plate Evaporators. As a solvent evaporator manufacturer, the company provides integrated products with various technologies that span the whole pharmaceutical value chain. The major end-users of the company’s products include pharmaceutical and biotechnology companies, government research institutes, consumer and healthcare product manufacturers, formulators, and diagnostic laboratories.

Recent Developments

  • Yamato Scientific relocated its headquarters to Tokyo, Japan.
  • Organomation Associates, Inc. partnered with BioChromato to provide a vacuum-assisted Smart Evaporator to customers in North America.
  • Yamato Scientific opened its new R&D Center in Saitama Prefecture, Japan.
  • Organomation Associates enhanced its MICROVAP product line with the addition of four new product offerings.

Request for Custom Research @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=68290365

Comments